130 related articles for article (PubMed ID: 33401422)
1. Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer.
Lepkes L; Kayali M; Blümcke B; Weber J; Suszynska M; Schmidt S; Borde J; Klonowska K; Wappenschmidt B; Hauke J; Kozlowski P; Schmutzler RK; Hahnen E; Ernst C
Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33401422
[TBL] [Abstract][Full Text] [Related]
2. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
[TBL] [Abstract][Full Text] [Related]
3. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA
BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725
[TBL] [Abstract][Full Text] [Related]
4. Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH.
Hackmann K; Kuhlee F; Betcheva-Krajcir E; Kahlert AK; Mackenroth L; Klink B; Di Donato N; Tzschach A; Kast K; Wimberger P; Schrock E; Rump A
Breast Cancer Res Treat; 2016 Oct; 159(3):585-90. PubMed ID: 27581129
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CNV detection tools for NGS panel data in genetic diagnostics.
Moreno-Cabrera JM; Del Valle J; Castellanos E; Feliubadaló L; Pineda M; Brunet J; Serra E; Capellà G; Lázaro C; Gel B
Eur J Hum Genet; 2020 Dec; 28(12):1645-1655. PubMed ID: 32561899
[TBL] [Abstract][Full Text] [Related]
6. panelcn.MOPS: Copy-number detection in targeted NGS panel data for clinical diagnostics.
Povysil G; Tzika A; Vogt J; Haunschmid V; Messiaen L; Zschocke J; Klambauer G; Hochreiter S; Wimmer K
Hum Mutat; 2017 Jul; 38(7):889-897. PubMed ID: 28449315
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic Variant Spectrum in Breast Cancer Risk Genes in Finnish Patients.
Nurmi AK; Suvanto M; Dennis J; Aittomäki K; Blomqvist C; Nevanlinna H
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551643
[TBL] [Abstract][Full Text] [Related]
8. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing.
Rosenthal SH; Sun W; Zhang K; Liu Y; Nguyen Q; Gerasimova A; Nery C; Cheng L; Castonguay C; Hiller E; Li J; Elzinga C; Wolfson D; Smolgovsky A; Chen R; Buller-Burckle A; Catanese J; Grupe A; Lacbawan F; Owen R
Biomed Res Int; 2020; 2020():3289023. PubMed ID: 32090079
[TBL] [Abstract][Full Text] [Related]
10. [The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].
Moretta J; Berthet P; Bonadona V; Caron O; Cohen-Haguenauer O; Colas C; Corsini C; Cusin V; De Pauw A; Delnatte C; Dussart S; Jamain C; Longy M; Luporsi E; Maugard C; Nguyen TD; Pujol P; Vaur D; Andrieu N; Lasset C; Noguès C;
Bull Cancer; 2018 Oct; 105(10):907-917. PubMed ID: 30268633
[TBL] [Abstract][Full Text] [Related]
11. The ICR96 exon CNV validation series: a resource for orthogonal assessment of exon CNV calling in NGS data.
Mahamdallie S; Ruark E; Yost S; Ramsay E; Uddin I; Wylie H; Elliott A; Strydom A; Renwick A; Seal S; Rahman N
Wellcome Open Res; 2017; 2():35. PubMed ID: 28630945
[TBL] [Abstract][Full Text] [Related]
12. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
Ryu JS; Lee HY; Cho EH; Yoon KA; Kim MK; Joo J; Lee ES; Kang HS; Lee S; Lee DO; Lim MC; Kong SY
Cancer Sci; 2020 Oct; 111(10):3912-3925. PubMed ID: 32761968
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Tools for Copy-Number Variation Detection in Germline Whole Exome and Whole Genome Sequencing Data.
Gabrielaite M; Torp MH; Rasmussen MS; Andreu-Sánchez S; Vieira FG; Pedersen CB; Kinalis S; Madsen MB; Kodama M; Demircan GS; Simonyan A; Yde CW; Olsen LR; Marvig RL; Østrup O; Rossing M; Nielsen FC; Winther O; Bagger FO
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944901
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
[TBL] [Abstract][Full Text] [Related]
15. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
[TBL] [Abstract][Full Text] [Related]
16. A Whole Germline BRCA2 Gene Deletion: How to Learn from CNV In Silico Analysis.
Scaglione GL; Concolino P; De Bonis M; De Paolis E; Minucci A; Ferrandina G; Scambia G; Capoluongo E
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29570666
[No Abstract] [Full Text] [Related]
17. Easy One-Step Amplification and Labeling Procedure for Copy Number Variation Detection.
Blesa S; Olivares MD; Alic AS; Serrano A; Lendinez V; González-Albert V; Olivares L; Martínez-Hervás S; Juanes JM; Marín P; Real JT; Navarro B; García-García AB; Chaves FJ; Ivorra C
Clin Chem; 2020 Mar; 66(3):463-473. PubMed ID: 32068788
[TBL] [Abstract][Full Text] [Related]
18. Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.
Fowler A; Mahamdallie S; Ruark E; Seal S; Ramsay E; Clarke M; Uddin I; Wylie H; Strydom A; Lunter G; Rahman N
Wellcome Open Res; 2016 Nov; 1():20. PubMed ID: 28459104
[No Abstract] [Full Text] [Related]
19. Evaluating the Calling Performance of a Rare Disease NGS Panel for Single Nucleotide and Copy Number Variants.
Cacheiro P; Ordóñez-Ugalde A; Quintáns B; Piñeiro-Hermida S; Amigo J; García-Murias M; Pascual-Pascual SI; Grandas F; Arpa J; Carracedo A; Sobrido MJ
Mol Diagn Ther; 2017 Jun; 21(3):303-313. PubMed ID: 28290094
[TBL] [Abstract][Full Text] [Related]
20. Rapid detection of copy number variations and point mutations in
Germani A; Libi F; Maggi S; Stanzani G; Lombardi A; Pellegrini P; Mattei M; De Marchis L; Amanti C; Pizzuti A; Torrisi MR; Piane M
Oncotarget; 2018 Sep; 9(72):33648-33655. PubMed ID: 30263092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]